Natural killer cell alloreactivity is not beneficial in haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for multiple myeloma: Results of a prospective phase 2 clinical trial

Publication date: October 2019Source: Clinical Lymphoma Myeloma and Leukemia, Volume 19, Issue 10, SupplementAuthor(s): Catharina Van Elssen, Gwendolyn Van Gorkom, Lotte Wieten, Peter von dem Borne, Ellen Meijer, Gerard Bos
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research